Lipella Pharmaceuticals annual revenue
2021
2022
2023
2024
Lipella Pharmaceuticals Revenue Growth & History (LIPO)
Lipella Pharmaceuticals reported $536,357 in revenue for fiscal 2024, an increase of 19.29% from the previous fiscal year.
View full Lipella Pharmaceuticals company overviewLipella Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $536,357 | $86,740 | +19.29% |
| 2023 | 2023-12-31 | $449,617 | $265,461 | +144.15% |
| 2022 | 2022-12-31 | $184,156 | −$75,191 | −28.99% |
| 2021 | 2021-12-31 | $259,347 | — | — |
Lipella Pharmaceuticals quarterly revenue
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | −$80,380 | −100.00% |
| Q2 2025 | 2025-06-30 | $86,727 | −$49,704 | −36.43% |
| Q1 2025 | 2025-03-31 | $129,390 | −$16,490 | −11.30% |
| Q4 2024 | 2024-12-31 | $173,666 | $52,824 | +43.71% |
| Q3 2024 | 2024-09-30 | $80,380 | −$23,671 | −22.75% |
| Q2 2024 | 2024-06-30 | $136,431 | $29,755 | +27.89% |
| Q1 2024 | 2024-03-31 | $145,880 | $27,832 | +23.58% |
| Q4 2023 | 2023-12-31 | $120,842 | −$30,165 | −19.98% |
| Q3 2023 | 2023-09-30 | $104,051 | $104,051 | — |
| Q2 2023 | 2023-06-30 | $106,676 | $106,676 | — |
| Q1 2023 | 2023-03-31 | $118,048 | $84,899 | +256.11% |
| Q4 2022 | 2022-12-31 | $151,007 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $33,149 | — | — |
Lipella Pharmaceuticals revenue growth trends
Lipella Pharmaceuticals's latest reported quarter, Q3 2025, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Lipella Pharmaceuticals source filings ↗